[Skip to content]

EPDA - European Parkinsons Disease Association EPDA - European Parkinsons Disease Association EPDA - Awareness EPDA - Coping Strategies EPDA - Medical Information EPDA - Patient Guide EPDA - Site Map EPDA - Rewrite Tomorrow
EUROPEAN PARKINSON'S DISEASE ASSOCIATION
.

Detection of presymptomatic Parkinson's disease: Combining smell tests, transcranial sonography, and SPECT

Movement Disorders

13 May 2004
Sommer U, Hummel T, Cormann K, Mueller A, Frasnelli J, Kropp J, Reichmann H.


Olfactory loss is among the early signs of Parkinson's disease (PD). We investigated whether idiopathic olfactory dysfunction might relate to signs of nigral degeneration.

Olfactory tests were combined with transcranial sonography of the substantia nigra and single photon emission computed tomography (SPECT) imaging. Thirty patients diagnosed with idiopathic olfactory loss participated. Eleven of these patients exhibited an increased echogenicity of the SN in the transcranial sonography.

In 10 of these 11 patients, SPECT scans with 123I-FP-CIT were performed. Median uptake ratios in the basal ganglia were pathological in 5 patients, 2 patients exhibited borderline findings, and 3 patients had normal results. Considering patients with idiopathic olfactory dysfunction, noninvasive transcranial sonography seems to be helpful in identifying patients potentially at risk to develop PD.

Longitudinal follow-up studies are necessary to estimate the ratio of patients with dopaminergic cell loss in the basal ganglia who will develop PD in the future.